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Abstract – The authors have paid attention to the changing termi-
nology that defines bladder-related disorders, which stems from 
the problematic ethiopathogenesis of the ailments. They have 
discussed selected issues related to bladder and urethra physiolo-
gy while being filled and emptied as well as sensitivity disorders 
of the bladder. They have characterised the epidemiology, clinical 
symptoms, and selected treatment methods of overactive bladder. 
A subject of another analysis was detrusor underactivity – the 
causes and some treatment methods have been discussed. The 
final disorder discussed here is stress incontinence. The authors 
have emphasised the significance of the ailments that “mask” 
stress incontinence, and highlighted the significance of diagnos-
tics and treatment. 
  
Key words - overactive bladder, detrusor underactivity, stress 
urinary incontinence,  diagnostics, treatment. 
 
Streszczenie – Autorzy zwrócili uwagę na zmieniającą się  termi-
nologię określenie zaburzeń czynności pęcherza moczowego co 
wynika z trudności właściwego ustalenia etiopatogenezy zabu-
rzeń. Omówili wybrane zagadnienia z fizjologii pęcherza moczo-
wego i cewki moczowej w trakcie napełniania i opróżniania oraz 
zaburzenia czucia pęcherzowego. Następnie scharakteryzowali 
epidemiologię występowania, objawy kliniczne i wybrane metody 
leczenia pęcherza nadreaktywnego. Przedmiotem analizy była 
także niewydolność skurczowa wypieracza. Omówiono przyczyny 
tej niewydolności oraz niektóre metody leczenia. Kolejnym 
omówionym zaburzeniem było wysiłkowe nietrzymanie moczu. 
Autorzy podkreślili rolę schorzeń „maskujących” wysiłkowe nie-
trzymanie moczu oraz znaczenie diagnostyki i leczenia. 
 
Słowa kluczowe pęcherz nadreaktywny, niewydolność skurczowa 
wypieracza, wysiłkowe nietrzymanie moczu, diagnostyka, lecze-
nie. 
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I. INTRODUCTION – TERMINOLOGY AND 
PHYSIOLOGY 
 
ver the years, various names were applied to define 
bladder disorders: spinal, spastic, contractile, auto-
matic, dyssynergic, unstable, or hyperreflectoric. 
This review of terminology allows one to conclude that, 
while some terms are based on descriptive attempts to 
characterise bladder activity, other ones are aimed at re-
flecting the neuropathologic process lying at the founda-
tions of micturition problems. Contemporary nomenclature 
has been ordered, but there are still two systems of classifi-
cation: a neurological and a functional one.  
Currently, the recommendations of the ICS (Internation-
al Continence Society) Standardisation Committee, the 
functional and descriptive terminology base established in 
1988 should be used [1]. It describes the parameters of 
bladder and urethra while they are being filled and emp-
tied. When it is being filled up, the bladder has to be a sta-
ble and susceptive container. All anomalies from that are 
pathological.  
The contractions that take place while bladder is being 
filled are considered as unstable bladder. When a bladder 
is small and has rigid walls, its susceptibility (increase in 
the internal pressure against the increase of volume) is de-
creased. The reverse – an excessively flexible and elastic 
bladder – is also an anomaly. It’s susceptibility is increased 
in that case, too [2].  
Bladder sensitivity disorders are related to oversensitive 
receptors (decreased sensitivity threshold) or decreased 
sensitivity (increased threshold, no sensitivity). The term 
“unstable detrusor” calls for some explanation. It is a func-
tional diagnosis made only on the basis of a urodynamic 
study. While it is not an ICS Standardisation Committee 
benchmark, it has been assumed that instability is a pres-
sure change when the bladder is being filled by more than 
15 cm H2O, regardless of the cause (be I neurological or 
idiopathic). When the bladder is filled, the urethral func-
tions might be correct or disrupted – in which case the 
stress incontinence occurs [1,3]. 
The emptying, or micturition, occurs when the urine 
leaves the bladder. The detrusor has to shrink as much as 
possible. However, sometimes the force of the contraction 
might be decreased, or the contraction might be impossi-
ble.   
The urine flow through urethra has to occur with the 
least resistance possible. Therefore, during micturition, the 
urethra should relax accordingly. However, sometimes 
there might be obstructions: anatomical ones (such as be-
nign enlargement of the prostate, narrow urethra, or poste-
rior urethral valves) or functional ones (such as detrusor or 
sphincter disorders, spastic sphincters). This type of de-
scriptive systematics of lower urinary tract functions allows 
one to define the disorder precisely [3]. 
On the other hand, it is not always the case that a urody-
namic study allows one to credibly and repetitively repro-
duce a patient’s ailments. This pertains predominantly to 
an “unstable detrusor”. This is why Paul Abrams proposed 
to introduce the term “overactive bladder” in 1997. Ac-
cording to his definition, symptomatic bladder overactivity 
is a condition when polyuria, urinary urgency, and urgency 
incontinence are the case – separately, or jointly, with no 
local pathological factors to explain the symptoms. Thus, 
the concept of “overactivity” stopped including the bladder 
disorders related to cancer, urolithiasis, or infections. The 
term “overactivity” is also no longer used in relation to 
neurogenic micturition disorders. For this group, the phrase 
“hyperreflexic bladder” is used [3,4]. 
Currently, both neurogenic and myogenic theories, as well 
as functional and structural theories, are significant in the 
explanation of overactivity ethiopathogenesis [5]. 
  
 
II. OVERACTIVE BLADDER – THE TREATMENT 
  
Overactive bladder (OAB) is a term for a disorder whose 
symptoms are urinary urgency with or without inconti-
nence, increased frequency of urination, and the need to 
urinate at night (nycturia).  
This ailment is a problem for approximately 16% of men 
and women over 40 years of age. Its frequency increases to 
70-80% over 80 years of age. It is the main reason for men 
to see a doctor because of “prostate problems”. In women, 
this disorder is more frequently accompanied by urinary 
incontinence [2]. OAB symptoms suggest the overactivity 
of the bladder detrusor muscle, but might as well be caused 
by other disorders of the lower urinary tract. The most dis-
turbing symptom is urinary urgency. It also generates other 
symptoms. The symptoms summary: 
 Urinary incontinence – it is a dire need to urinate 
which is very difficult or even impossible (urgency 
incontinence) to resist; 
 Urgency urinary incontinence – an involuntary leak of 
urine (of a large volume) occurring as a conse-
quence of urinary urgency and following it directly; 
 O 
● JOURNAL OF PUBLIC HEALTH, NURSING AND MEDICAL RESCUE ● No.3/2016 ● 
 
 
 
3 
 
 Increased frequency of urination during the day, which 
compels one to go to toilet more than 8 times in 24 
hours; 
 Nycturia – a need to wake up in the night at least once 
to urinate; 
 Overactive detrusor – detrusor contractions confirmed 
by a urodynamic study occurring when the bladder 
is being filled during cystometry. 
 
Overactive bladder is a clinical diagnosis formulated on 
the basis of symptoms, whereas detrusor overactivity (DO) 
is a diagnosis based on a urodynamic examination in which 
spontaneous contractions of the detrusor muscle are ob-
served when the bladder is being filled. Most OAB patients 
have overactive detrusors, which can be both idiopathic 
(with no diagnosed cause) and neurogenic – related to the 
nerves in the urinary tract as an outcome of  demyelinating 
diseases. The clinical diagnosis is based on the correctly 
collected medical history as well as on the analysis of a 
micturition diary kept by the patient for three days [6,7]. 
 
Treatment 
 
Lifestyle modifications, behavioural therapy, and anti-
muscarinic medication pharmacotherapy are the major 
treatment methods. Modifying one’s lifestyle and undergo-
ing a behavioural therapy consist in the patient changing his 
or her hydration habits (avoiding drinking 4 hours before 
sleep and before journeys) and in training one’s bladder, 
prolonging the periods before subsequent urinations. A 
clinically significant relief can be achieved by giving up 
beverages containing caffeine and alcohol and reducing the 
liquid intake by roughly 25%. These simple adaptation 
methods yield satisfying results in around 50% of patients. 
The treatment of more intense forms involves antimusca-
rinic medications (darifenacin, solifenacin, tolterodine, 
fesoterodine, trospium, oxybutynin and propiverine). The 
vasopressin analogue, desmopressin, can also be applied to 
decrease the nocturnal urine production. In the most diffi-
cult cases where there is no reaction to pharmacological 
treatment, the botulinum toxin injection to the detrusor 
muscle via cystoscope [8,9,10]. 
 
 
III. DETRUSOR UNDERACTIVITY – THE 
TREATMENT 
 
Detrusor underactivity (DU) manifests through micturi-
tion and post-micturition disorders and is a risk factor for 
recurrent urinary tract infections and urinary retention. The 
causes of detrusor underactivity are multifarious; among 
others, they are ageing, bladder outlet obstructions (BOO), 
neurological diseases and autonomic nervous system disor-
ders. The frequency of this pathology remains unknown. 
Collecting urological medial history is not sensitive 
enough, and the diagnosis is based on a urodynamic test. 
Detrusor underactivity (DU) is defined by ICS (Interna-
tional Commision on Stratigraphy) as a reduced force or 
duration of detrusor contraction which impacts prolonged 
or partial emptying of the bladder in the normal time. The 
term “bladder underactivity” is often used as a synonym to 
detrusor underactivity, but it is not according to the ICS 
definitions [1-3]. 
The phrase “detrusor contractility disorders”, defined as 
“decreased isometric detrusor pressure or/and the speed of 
urine flow in case of the absence of bladder outlet obstruc-
tion”  is also used interchangeably with “detrusor underac-
tivity”, and yet they are not the same. This is because the 
term “contractility disorders” pertains to the functioning of 
the detrusor muscle, whereas detrusor underactivity is more 
of a collection of all symptoms that includes all causes im-
pacting the emptying of the bladder. 
The causes of detrusor underactivity can be divided into 
[2,3]: 
 nervous background 
 muscle background 
 idiopathic 
 
The causes with the nervous background – the neurogen-
ic causes of detrusor underactivity – can be divided into 
metabolism-related disorders, central nervous system dis-
orders, peripheral nervous system disorders, and infection-
related disorders. 
A basic metabolic cause whose complications might lead 
to an underactive detrusor is diabetes. Diabetic patients 
develop a set of symptoms related to bladder that is re-
ferred to as diabetic cystopathy – it is constituted by the 
loss of bladder sensitivity and underactive detrusor (one 
failing to contract). Diabetes leads to polyneuropathy 
caused by changes to glucose metabolism resulting from 
the generation of oxygen free radicals and oxidative stress. 
Both the input and output bladder tract is damaged. The 
disability of the axonal transport of nerve growth factor 
(NGF) in the input tract impacts the bladder sensitivity 
negatively. The demyelination, axonal degeneration, and 
partial autonomous denervation impact the output tract and 
cause changes to the bladder contractibility. The damage to 
small blood vessels may contribute to the decline in the 
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functioning of the nerves as well. The frequency of detrusor 
underactivity in diabetic patients is estimated to be between 
23-78% in different studies [11]. 
The disorders to the central nervous system are usually 
related to multiple sclerosis (SM). SM is a chronic and a 
rapidly progressing disease which consists in the demyeli-
sation of the central nervous system with deteriorating neu-
rological deficit being the consequence. If the changes af-
fect the cervical section of the spinal cord, 50–80% of pa-
tients are diagnosed with overactive bladder (OAB) and/or 
detrusor sphincter dyssynergia (DSD) in a urodynamic test.  
However, some changes can affect the cervical-thoracic 
section of the spinal cord and in that case, around 30% of 
patients suffer from underactive detrusor or non-contractile 
detrusor.  
In case of Parkinson’s, the gradual degeneration of cen-
tral nervous system nuclei neurons leads to neurotransmit-
ter (dopamine) deficiency, which results in muscle trem-
bling and stiffness and slowed down movement. Most pa-
tients suffering from this ailment are overactive, and yet 
16% suffer from underactive or non-contractile detrusor. 
During surgeries to the pelvic areas, parasympathetic, 
sympathetic, and somatic nerves might get damaged, caus-
ing detrusor underactivity. The surgeries most often related 
to the iatrogenic mechanism of DU development are: ab-
dominoperineal rectum resection and radical hysterectomy. 
Pelvis fractures and spinal disc hernias causing a cauda 
equina syndrome may also potentially cause DU, even 
though the frequency of that remain unknown. 
Sometimes even infection can cause DU – e.g. AIDS, 
nervous system syphilis, zoster, HSV infection, Guillain-
Barre syndrome or Lyme disease [5,6,12]. 
 
 
IV. STRESS INCONTINENCE – THE TREATMENT 
 
Stress incontinence is defined as involuntary urine leak 
caused by the increased pressure in the stomach occurring 
because of a physical strain (during cough, climbing stairs, 
lifting heavy objects). It is one of the most common causes 
for women to seek medical attention. This ailment is very 
infrequent in men, for whom it occurs most often as an out-
come of prostate surgeries. Stress incontinence in women is 
often accompanied by pelvic floor statics disorders, which 
mask the occurrence of stress incontinence [5].  
Therefore, after treating coleoptosia or uterovaginal pro-
lapse, one should always apply the cough test. It has to be 
emphasised that some patients experience mixed types of 
incontinence: urgency incontinence (involuntary leak of a 
large volume of urine, which follows the sensation of ur-
gency) and stress incontinence.  
Stress incontinence is caused by the urethral sphincter 
underactivity, which, in turn, implies the possibility of con-
servative treatment by behavioural techniques and pelvic 
floor muscle exercise. An important phase of the therapeu-
tic treatment is the avoidance of diuretic medications, con-
trolling chronic cough and constipation, the treatment of 
urinary tract infections, and body weight reduction in cases 
of significant overweight. One has to mention also a new 
therapeutic option – duloxetine. However, only an insignif-
icant percentage of female patients are completely cured 
after treatment with this drug. Conservative treatment can 
be an effective option only if the stress incontinence is a 
less intense one. If the symptoms are more intensified, the 
only right way to go is a surgery – a Burch colposuspension 
and mid-urethral slings fixed under the centre part of ure-
thra via retropubic access or obturator foramina [3,5,8,12]. 
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